NGNE
Neurogene Inc.
There isn't enough reported data to score NGNE yet.
NGNE Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
NGNE's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
NGNE PE Valuation
NGNE has no meaningful PE right now: it lost money over the past year.
NGNE Forward outlook
There aren't enough analyst estimates for NGNE to show an outlook.
NGNE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$5.09 | -$0.97 |
| Q2 2026 | -$5.03 | -$0.71 |
| Q1 2026 | -$4.55 | -$0.19 |
| Q4 2025 | -$4.24 | +$0.04 |
| Q3 2025 | -$4.12 | +$0.56 |
| Q2 2025 | -$4.32 | +$0.81 |
| Q1 2025 | -$4.36 | +$0.48 |
| Q4 2024 | -$4.28 | +$4.76 |
NGNE is still losing money, but far less than before: $5.09 per share over the past year, against $57.20 at its worst in mid-2020.
NGNE Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2024 | -2177% | N/A |
NGNE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$29.5M | -$9.8M |
| Q2 2026 | -$24.1M | -$4.5M |
| Q1 2026 | -$26.4M | -$4.8M |
| Q4 2025 | -$17.6M | +$55K |
| Q3 2025 | -$19.6M | -$3.9M |
| Q2 2025 | -$19.6M | -$3.3M |
| Q1 2025 | -$21.6M | +$161K |
| Q4 2024 | -$17.6M | +$12.2M |
NGNE has burned cash in almost every quarter: −$98M over the past year, against −$78M the year before.
NGNE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +23% | +5.1M shares |
| 1 year | +32% | +6.6M shares |
| 3 years | +886% | +24.9M shares |
| 5 years | +969% | +25.1M shares |
NGNE has 28M diluted shares, up 32% from a year ago.
NGNE Net Leverage
NGNE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NGNE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 21.6 | Neutral |
NGNE's weekly RSI is 42 (neutral) and its Stochastic is 22 (neutral).
NGNE PE vs Healthcare Sector
NGNE has no meaningful PE right now: it lost money over the past year.
NGNE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.5 | 6.2% below |
| 20 week MA | $31.9 | 25% below |
| 50 week MA | $26.6 | 10% below |
| 100 week MA | $23.1 | 3.6% above |
| 200 week MA | $24.4 | 2.2% below |
NGNE's trend is mixed: it's above one of its five weekly moving averages, and 2.2% below its 200-week average.
NGNE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $243.6 | $291.2 | +20% |
| 2021 | $291.2 | $110.4 | -62% |
| 2022 | $110.4 | $8.66 | -92% |
| 2023 | $8.66 | $19.4 | +124% |
| 2024 | $19.4 | $23.0 | +19% |
| 2025 | $23.0 | $20.0 | -13% |
| 2026 YTD | $20.0 | $23.9 | +19% |
NGNE's yearly returns have swung widely, from +124% in 2023 to −92% in 2022. It's up 19% so far in 2026.